Who
Laura J. Schumacher
Director
Company insider
Files Form 4 as: Director, CrowdStrike Holdings; Director, General Dynamics; Vice Chairman, AbbVie; Executive Vice President, Abbott Laboratories.
In numbers
- Trades disclosed
- 567
- Buys
- 1
- Sells
- 36
- Bought
- $1.8M
- Sold
- $99.8M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 17 Feb 2006
- Last trade
- 18 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 21 Sep 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —68 at $0.00 | filing |
| 18 Sep 2026filed 21 Sep 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —68 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | $37K105 at $356.69 | filing |
| 16 Sep 2026filed 18 Sep 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | $37K105 at $356.69 | filing |
| 18 Jun 2026filed 22 Jun 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —23 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —23 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —402 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —402 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | $37K104 at $359.85 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | $37K104 at $359.85 | filing |
| 20 Mar 2026filed 23 Mar 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —39 at $0.00 | filing |
| 20 Mar 2026filed 23 Mar 2026 | CRWD CrowdStrike HoldingsCybersecurity | SEC FORM 4 Code A | —39 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | $37K105 at $354.31 | filing |
| 17 Mar 2026filed 19 Mar 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | $37K105 at $354.31 | filing |
| 9 Mar 2026filed 11 Mar 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code F | $30K83 at $359.79 | filing |
| 9 Mar 2026filed 11 Mar 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code F | $30K83 at $359.79 | filing |
| 4 Mar 2026filed 6 Mar 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | —270 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | GD General Dynamicsoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —1,120 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | GD General Dynamicsoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —1,120 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | GD General DynamicsAerospace & Defense | SEC FORM 4 Code A | —270 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
AbbVie: SKYRIZI (risankizumab) and RINVOQ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026ABBV · finanznachrichten.de · 17 Oct 2026Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?ABBV · insidermonkey.com · 16 Oct 2026AbbVie vs. Merck: Which Pharma Stock Offers Better Value?ABBV · insidermonkey.com · 16 Oct 2026Abbott Laboratories (NYSE:ABT) Given "Buy" Rating at TD CowenABT · dailypolitical.com · 16 Oct 2026General Dynamics Land Systems showing CUAS & armored vehicle at AUSA 2026GD · militaryembedded.com · 13 Oct 2026Tag: general_dynamics_phebe_novakovicGD · newsroomamerica.com · 12 Oct 2026General Dynamics Names Danny Deep CEO for January 2027GD · finchannel.com · 11 Oct 2026Abbott Laboratories is More than a Dividend Stock. Here's Why.ABT · insidermonkey.com · 11 Oct 2026
0 headlines in the last 90 days name Laura J. Schumacher; 9 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.